Glycogen synthase kinase 3β and cyclin D1 expression in cervical carcinogenesis
2
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
ObjectiveGlycogen synthase kinase 3β (GSK3β) is a pluripotent protein kinase involved in the development of cancers through regulation of numerous oncogenic molecules. Cyclin D1, an important regulator of G1 to S phase transition in various cells, is one of target proteins that GSK3β regulate. Our objective was to assess the expression of GSK3β and cyclin D1 in cervical neoplasm of different histologic grades and to identify their correlation in cervical carcinogenesis. MethodsImmunohistochemical analysis of GSK3β and cyclin D1 was performed in a total of 137 patients with 12 normal, 62 cervical intraepithelial neoplasia (CIN) (31 CIN1 and 31 CIN3) and 63 invasive cancers including 56 squamous cell carcinomas and 7 adenocarcinomas. ResultsThe expression of GSK3β increased in parallel with the lesion grade, while that of cyclin D1 decreased with severity of the lesion (P<0.001). There was a significant inverse correlation between GSK3β and cyclin D1 expression in overall cervical neoplasia (φ=-0.413, P<0.001). GSK3β expression was higher in squamous cell carcinoma than in adenocarcinoma (P=0.049). ConclusionThese results suggest that the expressional increase in GSK3β plays a role in cervical carcinogenesis and has inverse correlation with cyclin D1 expression in this process. In addition, GSK3β expression appears to be associated with the histologic type of cervical cancer, especially squamous cell carcinoma.
Abstract
ObjectiveGlycogen synthase kinase 3β (GSK3β) is a pluripotent protein kinase involved in the development of cancers through regulation of numerous oncogenic molecules. Cyclin D1, an important regulator of G1 to S phase transition in various cells, is one of target proteins that GSK3β regulate. Our objective was to assess the expression of GSK3β and cyclin D1 in cervical neoplasm of different histologic grades and to identify their correlation in cervical carcinogenesis. MethodsImmunohistochemical analysis of GSK3β and cyclin D1 was performed in a total of 137 patients with 12 normal, 62 cervical intraepithelial neoplasia (CIN) (31 CIN1 and 31 CIN3) and 63 invasive cancers including 56 squamous cell carcinomas and 7 adenocarcinomas. ResultsThe expression of GSK3β increased in parallel with the lesion grade, while that of cyclin D1 decreased with severity of the lesion (P<0.001). There was a significant inverse correlation between GSK3β and cyclin D1 expression in overall cervical neoplasia (φ=-0.413, P<0.001). GSK3β expression was higher in squamous cell carcinoma than in adenocarcinoma (P=0.049). ConclusionThese results suggest that the expressional increase in GSK3β plays a role in cervical carcinogenesis and has inverse correlation with cyclin D1 expression in this process. In addition, GSK3β expression appears to be associated with the histologic type of cervical cancer, especially squamous cell carcinoma.
참고문헌 (40)
- "Human papillomavirus and related diseases report" (2016)[URL]
- zur Hausen H, "Papillomaviruses causing cancer : evasion from host-cell control in early events in carcinogenesis", J Natl Cancer Inst, 92, pp.690~698 (2000)
- Bahnassy AA, "The possible role of cell cycle regulators in multistep process of HPV-associated cervical carcinoma", BMC Clin Pathol, 7, pp.4~ (2007)
- Doorbar J, "Molecular biology of human papillomavirus infection and cervical cancer", Clin Sci (Lond), 110, pp.525~541 (2006)
- Howley PM, "Oncoproteins encoded by the cancer-associated human papillomaviruses target the products of the retinoblastoma and p53 tumor suppressor genes", Cold Spring Harb Symp Quant Biol, 56, pp.149~155 (1991)
- Moody CA, "Human papillomavirus oncoproteins : pathways to transformation", Nat Rev Cancer, 10, pp.550~560 (2010)
- Perez-Plasencia C, "Genome wide expression analysis in HPV16 cervical cancer : identification of altered metabolic pathways", Infect Agent Cancer, 2, pp.16~ (2007)
- Vandermark ER, "Human papillomavirus type 16 E6 and E 7 proteins alter NF-kB in cultured cervical epithelial cells and inhibition of NF-kB promotes cell growth and immortalization", Virology, 425, pp.53~60 (2012)
- Doble BW, "GSK-3: tricks of the trade for a multi-tasking kinase", J Cell Sci, 116(Pt 7), pp.1175~1186 (2003)
- Jope RS, "The glamour and gloom of glycogen synthase kinase-3", Trends Biochem Sci, 29, pp.95~102 (2004)
- McCubrey JA, "GSK-3 as potential target for therapeutic intervention in cancer", Oncotarget, 5, pp.2881~2911 (2014)
- Sears R, "Multiple Ras-dependent phosphorylation pathways regulate Myc protein stability", Genes Dev, 14, pp.2501~2514 (2000)
- Tullai JW, "Glycogen synthase kinase-3 represses cyclic AMP response element-binding protein(CREB)-targeted immediate early genes in quiescent cells", J Biol Chem, 282, pp.9482~9491 (2007)
- Diehl JA, "Glycogen synthase kinase-3beta regulates cyclin D1 proteolysis and subcellular localization", Genes Dev, 12, pp.3499~3511 (1998)
- Ougolkov AV, "Aberrant nuclear accumulation of glycogen synthase kinase-3beta in human pancreatic cancer : association with kinase activity and tumor dedifferentiation", Clin Cancer Res, 12, pp.5074~5081 (2006)
- Karrasch T, "PI3K-dependent GSK3ß(Ser9)-phosphorylation is implicated in the intestinal epithelial cell wound-healing response", PLoS One, 6, pp.e26340~ (2011)
- Mishra R, "Glycogen synthase kinase 3 beta : can it be a target for oral cancer", Mol Cancer, 9, pp.144~ (2010)
- Mishra R, "Expression and inactivation of glycogen synthase kinase 3 alpha", beta and their association with the expression of cyclin D1 and p53 in oral squamous cell carcinoma progression, 2015, pp.14, 20~
- Shakoori A, "Inhibition of GSK-3 beta activity attenuates proliferation of human colon cancer cells in rodents", Cancer Sci, 98, pp.1388~1393 (2007)
- Naito S, "Glycogen synthase kinase-3beta : a prognostic marker and a potential therapeutic target in human bladder cancer", Clin Cancer Res, 16, pp.5124~5132 (2010)
- Cao Q, "Glycogen synthase kinase-3beta positively regulates the proliferation of human ovarian cancer cells", Cell Res, 16, pp.671~677 (2006)
- Bilim V, "Glycogen synthase kinase-3 : a new therapeutic target in renal cell carcinoma", Br J Cancer, 101, pp.2005~2014 (2009)
- Miyashita K, "Potential therapeutic effect of glycogen synthase kinase 3beta inhibition against human glioblastoma", Clin Cancer Res, 15, pp.887~897 (2009)
- Kato J, "Direct binding of cyclin D to the retinoblastoma gene product(pRb)and pRb phosphorylation by the cyclin Ddependent kinase CDK4", Genes Dev, 7, pp.331~342 (1993)
- Leone G, "Collaborative role of E2F transcriptional activity and G1cyclindependent kinase activity in the induction of S phase", Proc Natl Acad Sci U S A, 96, pp.6626~6631 (1999)
- Bartkova J, "Abnormal patterns of D-type cyclin expression and G1 regulation in human head and neck cancer", Cancer Res, 55, pp.949~956 (1995)
- Cheung TH, "Alteration of cyclin D1 and CDK4 gene in carcinoma of uterine cervix", Cancer Lett, 166, pp.199~206 (2001)
- Ma C, "The role of glycogen synthase kinase 3beta in the transformation of epidermal cells", Cancer Res, 67, pp.7756~7764 (2007)
- Skomedal H, "Aberrant expression of the cell cycle associated proteins TP53, MDM2, p21, p27, cdk4, cyclin D1, RB, and EGFR in cervical carcinomas", Gynecol Oncol, 73, pp.223~228 (1999)
- Cho NH, "Correlation between G1 cyclins and HPV in the uterine cervix", Int J Gynecol Pathol, 16, pp.339~347 (1997)
- Bae DS, "Aberrant expression of cyclin D1 is associated with poor prognosis in early stage cervical cancer of the uterus", Gynecol Oncol, 81, pp.341~347 (2001)
- Rath G, "Clinical significance of inactivated glycogen synthase kinase 3β in HPV-associated cervical cancer : Relationship with Wnt", β-catenin pathway activation, 2015, pp.73, 460~478
- Choi SK, "Overexpression of PI3K-p110α in the progression of uterine cervical neoplasia and its correlation with pAkt and DJ-1", Eur J Gynaecol Oncol, 36, pp.389~393 (2015)
- de Groot RP, "Negative regulation of Jun", AP-1 : conserved function of glycogen synthase kinase 3 and the Drosophila kinase shaggy, 1993, pp.8, 841~847
- Manoukian AS, "Role of glycogen synthase kinase-3 in cancer : regulation by Wnts and other signaling pathways", Adv Cancer Res, 84, pp.203~229 (2002)
- Nichols GE, "Cyclin D1 gene expression in human cervical neoplasia", Mod Pathol, 9, pp.418~425 (1996)
- Lukas J, "DNA tumor virus oncoproteins and retinoblastoma gene mutations share the ability to relieve the cell’s requirement for cyclin D1 function in G1", J Cell Biol, 125, pp.625~638 (1994)
- Koay MH, "Cyclin D1, E-cadherin and beta-catenin expression in FIGO Stage IA cervical squamous carcinoma: diagnostic value and evidence for epithelial-mesenchymal transition", Histopathology, 61, pp.1125~1133 (2012)
- Casimiro MC, "Cyclins and cell cycle control in cancer and disease", Genes Cancer, 3, pp.649~657 (2012)
- Li Z, "Cyclin D1functions in cell migration", Cell Cycle, 5, pp.2440~2442 (2006)
